Lv1
42 积分 2023-09-21 加入
A clinical population pharmacokinetic/pharmacodynamic model for BIIB059, a monoclonal antibody for the treatment of systemic and cutaneous lupus erythematosus
23天前
已完结
Llamanade: An open-source computational pipeline for robust nanobody humanization
24天前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
1个月前
已完结
The race to reset autoimmune diseases
1个月前
已完结
Anti-VEGFR2-Interferon α Promotes the Infiltration of CD8+ T Cells in Colorectal Cancer by Upregulating the Expression of CCL5
1个月前
已完结
Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation
2个月前
已完结
Pharmacokinetics analysis based on target-mediated drug distribution for RC18, a novel BLyS/APRIL fusion protein to treat systemic lupus erythematosus and rheumatoid arthritis
2个月前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT‐18 in Chinese Patients With Systemic Lupus Erythematosus
2个月前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
3个月前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
3个月前
已完结
皖公网安备34019202002308
